371 related articles for article (PubMed ID: 22958493)
1. VEGF and podocytes in diabetic nephropathy.
Tufro A; Veron D
Semin Nephrol; 2012 Jul; 32(4):385-93. PubMed ID: 22958493
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.
Bertuccio C; Veron D; Aggarwal PK; Holzman L; Tufro A
J Biol Chem; 2011 Nov; 286(46):39933-44. PubMed ID: 21937443
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
[TBL] [Abstract][Full Text] [Related]
4. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
[TBL] [Abstract][Full Text] [Related]
5. The podocyte: a potential therapeutic target in diabetic nephropathy?
Marshall SM
Curr Pharm Des; 2007; 13(26):2713-20. PubMed ID: 17897015
[TBL] [Abstract][Full Text] [Related]
6. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
[TBL] [Abstract][Full Text] [Related]
7. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
8. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
9. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
Fu J; Lee K; Chuang PY; Liu Z; He JC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
11. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
Veron D; Bertuccio CA; Marlier A; Reidy K; Garcia AM; Jimenez J; Velazquez H; Kashgarian M; Moeckel GW; Tufro A
Diabetologia; 2011 May; 54(5):1227-41. PubMed ID: 21318407
[TBL] [Abstract][Full Text] [Related]
12. VEGF and the diabetic kidney: More than too much of a good thing.
Majumder S; Advani A
J Diabetes Complications; 2017 Jan; 31(1):273-279. PubMed ID: 27836681
[TBL] [Abstract][Full Text] [Related]
13. Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology.
Gruden G; Perin PC; Camussi G
Curr Diabetes Rev; 2005 Feb; 1(1):27-40. PubMed ID: 18220580
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between expressions of VEGF and TRPC6 and their roles in podocyte injury in rats with diabetic nephropathy].
Zhu XN; Wang YH; Wu JJ; Dong P; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):296-304. PubMed ID: 29643035
[TBL] [Abstract][Full Text] [Related]
15. Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury.
Miaomiao W; Chunhua L; Xiaochen Z; Xiaoniao C; Hongli L; Zhuo Y
Mol Biosyst; 2016 Jun; 12(7):2202-12. PubMed ID: 27138352
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
[TBL] [Abstract][Full Text] [Related]
17. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
[TBL] [Abstract][Full Text] [Related]
18. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
19. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
[TBL] [Abstract][Full Text] [Related]
20. eNOS deficiency predisposes podocytes to injury in diabetes.
Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]